These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28135785)

  • 1. Changes in cardiac output and incidence of volume overload in cirrhotics receiving 20% albumin infusion.
    Shasthry SM; Kumar M; Khumuckham JS; Sarin SK
    Liver Int; 2017 Aug; 37(8):1167-1176. PubMed ID: 28135785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosis.
    Voiosu AM; Wiese S; Voiosu TA; Hove J; Bendtsen F; Møller S
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):392-397. PubMed ID: 29227330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin infusion may deleteriously promote extracellular fluid overload without improving circulating hypovolemia in patients of advanced cirrhosis with diabetes mellitus and sepsis.
    Kumar R; Kumar S; Lata S
    Med Hypotheses; 2013 Apr; 80(4):452-5. PubMed ID: 23375411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiac response to exercise in cirrhosis.
    Wong F; Girgrah N; Graba J; Allidina Y; Liu P; Blendis L
    Gut; 2001 Aug; 49(2):268-75. PubMed ID: 11454805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
    Schneditz D; Bachler I; Stadlbauer V; Stauber RE
    Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis.
    Sampaio F; Pimenta J; Bettencourt N; Fontes-Carvalho R; Silva AP; Valente J; Bettencourt P; Fraga J; Gama V
    Eur J Intern Med; 2014 Mar; 25(3):241-6. PubMed ID: 24485543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease.
    Merli M; Calicchia A; Ruffa A; Pellicori P; Riggio O; Giusto M; Gaudio C; Torromeo C
    Eur J Intern Med; 2013 Mar; 24(2):172-6. PubMed ID: 22958907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.
    Sampaio F; Pimenta J; Bettencourt N; Fontes-Carvalho R; Silva AP; Valente J; Bettencourt P; Fraga J; Gama V
    Liver Int; 2013 Sep; 33(8):1158-65. PubMed ID: 23617332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of cardiac function in cirrhotic patients with and without ascites.
    Valeriano V; Funaro S; Lionetti R; Riggio O; Pulcinelli G; Fiore P; Masini A; De Castro S; Merli M
    Am J Gastroenterol; 2000 Nov; 95(11):3200-5. PubMed ID: 11095342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic dysfunction characterizes cirrhotic cardiomyopathy.
    Somani PO; Contractor Q; Chaurasia AS; Rathi PM
    Indian Heart J; 2014; 66(6):649-55. PubMed ID: 25634400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new software version of the FloTrac/Vigileo (version 3.02) and a comparison with previous data in cirrhotic patients undergoing liver transplant surgery.
    Biancofiore G; Critchley LA; Lee A; Yang XX; Bindi LM; Esposito M; Bisà M; Meacci L; Mozzo R; Filipponi F
    Anesth Analg; 2011 Sep; 113(3):515-22. PubMed ID: 21680855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological basis of albumin use in cirrhosis.
    Arroyo V; Fernandez J
    Ann Hepatol; 2011 May; 10 Suppl 1():S6-14. PubMed ID: 21566249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodal cardiac dysfunction in an animal model of iron overload.
    Yang T; Dong WQ; Kuryshev YA; Obejero-Paz C; Levy MN; Brittenham GM; Kiatchoosakun S; Kirkpatrick D; Hoit BD; Brown AM
    J Lab Clin Med; 2002 Oct; 140(4):263-71. PubMed ID: 12389025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?
    Hammami R; Boudabbous M; Jdidi J; Trabelsi F; Mroua F; Kallel R; Amouri A; Abid D; Tahri N; Abid L; Kammoun S
    Libyan J Med; 2017 Dec; 12(1):1283162. PubMed ID: 28245727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhotic cardiomyopathy.
    Zardi EM; Abbate A; Zardi DM; Dobrina A; Margiotta D; Van Tassell BW; Afeltra A; Sanyal AJ
    J Am Coll Cardiol; 2010 Aug; 56(7):539-49. PubMed ID: 20688208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.
    Henriksen JH; Fuglsang S; Bendtsen F; Møller S
    Gut; 2006 Mar; 55(3):380-7. PubMed ID: 16474108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: Relationship with diastolic dysfunction.
    Filì D; Falletta C; Luca A; Hernandez Baravoglia C; Clemenza F; Miraglia R; Scardulla C; Tuzzolino F; Vizzini G; Gridelli B; Bosch J
    Dig Liver Dis; 2015 Dec; 47(12):1052-8. PubMed ID: 26427586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume overload modulates effects of cardiac resynchronization therapy independently of myocardial reperfusion: results of the RESYNC study.
    Gimelli A; Stanislao M; Valle G; Frumento P; Zanco P; Ometto R; Inglese E; Martino G; Startari U; Bertelli P; Marzullo P
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):575-81. PubMed ID: 17667027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.